BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu J, Song XY, Li XT, Yang M, Wang F, Han Y, Jiang Y, Lei YX, Jiang M, Zhang W, Tang DQ. β-Arrestin-2 enhances endoplasmic reticulum stress-induced glomerular endothelial cell injury by activating transcription factor 6 in diabetic nephropathy. World J Diabetes 2024; 15(12): 2322-2337 [PMID: 39676815 DOI: 10.4239/wjd.v15.i12.2322]
URL: https://www.wjgnet.com/2220-6124/full/v15/i12/2322.htm
Number Citing Articles
1
Jian Yang, Cheng-Zhi Zhang, Jing Zhang. From metabolic regulation to kidney protection: β-arrestin 2 as a dual-function therapeutic targetWorld Journal of Diabetes 2025; 16(3): 102014 doi: 10.4239/wjd.v16.i3.102014
2
Ariella C. Avigad, Melody Zhou, Chengyu Sun, Levin Ma, Xue Li, Rosie J. Blodgett, Vera S. Donnenberg, Albert D. Donnenberg, Patrick L. Wagner, David L. Bartlett, Kunhong Xiao. Pharmacology of GPCRs Biased Signaling and AgonistsHandbook of Experimental Pharmacology 2025; 290: 277 doi: 10.1007/164_2025_773
3
Na Liu, Wei-Tao Yan, Kun Xiong. Exploring a novel mechanism for targeting β-arrestin-2 in the management of diabetic nephropathyWorld Journal of Diabetes 2025; 16(4): 101994 doi: 10.4239/wjd.v16.i4.101994